UniProtKB/Swiss-Prot Q9UNI1: Variant p.Gly76Ala

Chymotrypsin-like elastase family member 1
Gene: CELA1
Feedback?

Variant information Variant position:

76 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glycine (G) to Alanine (A) at position 76 (G76A, p.Gly76Ala). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from glycine (G) to small size and hydrophobic (A) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In a breast cancer sample; somatic mutation. Any additional useful information about the variant.

Sequence information Variant position:

76 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

258 The length of the canonical sequence.
Location on the sequence:

NWVMTAAHCVDYQKTFRVVA G DHNLSQNDGTEQYVSVQKIV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         NWVMTAAHCVDYQKTFRVVAGDHNLSQNDGTEQYVSVQKIV

                              NWVMTAAHCVDRTMTFRVVIGEHNLSQNDGTEQSASVQKIV

Mouse                         NWVMTAAHCVDSPMTYRVVVGEHNLSQNDGTEQYVNVQKIV

Rat                           NWVMTAAHCVSSQMTFRVVVGDHNLSQNDGTEQYVSVQKIM

Pig                           NWVMTAAHCVDRELTFRVVVGEHNLNQNDGTEQYVGVQKIV

Bovine                        KWVMTAAHCVDSQMTFRVVLGDHNLSQNDGTEQYISVQKIV

Cat                           NWVMTAAHCVDRKMTFRVVAGEHNLSQNDGTEQRVSVQKIV

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	19 – 258	Chymotrypsin-like elastase family member 1
Domain	19 – 256	Peptidase S1
Active site	63 – 63	Charge relay system
Binding site	77 – 77
Binding site	79 – 79
Binding site	82 – 82
Binding site	87 – 87
Glycosylation	79 – 79	N-linked (GlcNAc...) asparagine

Literature citations
The consensus coding sequences of human breast and colorectal cancers.
Sjoeblom T.; Jones S.; Wood L.D.; Parsons D.W.; Lin J.; Barber T.D.; Mandelker D.; Leary R.J.; Ptak J.; Silliman N.; Szabo S.; Buckhaults P.; Farrell C.; Meeh P.; Markowitz S.D.; Willis J.; Dawson D.; Willson J.K.V.; Gazdar A.F.; Hartigan J.; Wu L.; Liu C.; Parmigiani G.; Park B.H.; Bachman K.E.; Papadopoulos N.; Vogelstein B.; Kinzler K.W.; Velculescu V.E.;
Science 314:268-274(2006)
Cited for: VARIANT [LARGE SCALE ANALYSIS] ALA-76;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.